HLA-G gene repression is reversed by demethylation

被引:136
作者
Moreau, P
Mouillot, G
Rousseau, P
Marcou, C
Dausset, J
Carosella, ED
机构
[1] Hop St Louis, Inst Univ Hematol, CEA,Serv Rech Hamatoimmunol, Direct Sci Vivant,Dept Rech Med, F-75010 Paris, France
[2] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France
关键词
D O I
10.1073/pnas.0337539100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HLA-G molecule plays an important role in immune tolerance, protecting the fetus from maternal immune attack, and probably contributes to graft tolerance and tumor escape from the host immune system. HLA-G expression is tightly regulated and involves mechanisms acting in part at the transcriptional level. Nevertheless, almost all regulatory sequences that govern constitutive and inducible HLA class I gene transcription are disrupted in the HLA-G gene promoter, suggesting an unusual regulatory process. In further investigating the molecular mechanisms of HLA-G gene activation, we evaluated the influence of epigenetic mechanisms on seven HLA-G-negative cell lines that exhibit various phenotypes. Exposure of cells to histone deacetylase inhibitors, or to the demethylating agent 5-aza-2'-deoxycytidine, revealed that HLA-G gene transcription is inhibited by DNA methylation. Reversal of methylation-mediated repression may directly induce HLA-G cell-surface expression, supporting the idea that HLA-G might be activated by such a mechanism during malignancy, inflammation, and allogenic reactions.
引用
收藏
页码:1191 / 1196
页数:6
相关论文
共 71 条
  • [1] HLA-G class I gene expression in normal and malignant hematopoietic cells
    Amiot, L
    Onno, M
    Drénou, B
    Monvoisin, C
    Fauchet, R
    [J]. HUMAN IMMUNOLOGY, 1998, 59 (08) : 524 - 528
  • [2] HLA-G and NK receptor are expressed in psoriatic skin - A possible pathway for regulating infiltrating T cells?
    Aractingi, S
    Briand, N
    Le Danff, C
    Viguier, M
    Bachelez, H
    Michel, L
    Dubertret, L
    Carosella, ED
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) : 71 - 77
  • [3] Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells
    Bamberger, AM
    Jenatschke, S
    Schulte, HM
    Löning, T
    Bamberger, CM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) : 3932 - 3936
  • [4] DNA methylation patterns and epigenetic memory
    Bird, A
    [J]. GENES & DEVELOPMENT, 2002, 16 (01) : 6 - 21
  • [5] Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
    Blaschitz, A
    Lenfant, F
    Mallet, V
    Hartmann, M
    Bensussan, A
    Geraghty, DE
    Le Bouteiller, P
    Dohr, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3380 - 3388
  • [6] HLA-G: a shield against inflammatory aggression
    Carosella, ED
    Moreau, P
    Aractingi, S
    Rouas-Freiss, N
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (10) : 553 - 555
  • [7] Colonna M, 1998, J IMMUNOL, V160, P3096
  • [8] A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
    Colonna, M
    Navarro, F
    Bellon, T
    Llano, M
    Garcia, P
    Samaridis, J
    Angman, L
    Cella, M
    LopezBotet, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) : 1809 - 1818
  • [9] Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation
    Copeman, J
    Han, RNN
    Caniggia, I
    McMaster, M
    Fisher, SJ
    Cross, JC
    [J]. BIOLOGY OF REPRODUCTION, 2000, 62 (06) : 1543 - 1550
  • [10] A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
    Cosman, D
    Fanger, N
    Borges, L
    Kubin, M
    Chin, W
    Peterson, L
    Hsu, ML
    [J]. IMMUNITY, 1997, 7 (02) : 273 - 282